NCT07481981: A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension